Literature DB >> 16487393

Spontaneous neonatal chylothorax treated with octreotide.

Sylvia L Y Siu1, David S Y Lam.   

Abstract

Chylothorax is the most common cause of pleural effusion causing respiratory distress in the neonate. Cases unresponsive to conservative management usually require surgery. We report a case of spontaneous neonatal chylothorax where surgery was avoided with the compassionate trail of octreotide. The chylothorax resolved promptly with no observed side effects. After reviewing the literature reporting the use of octreotide in the neonatal period, we found that neonates with isolated spontaneous chylothorax might be viewed as a group different from those with major cardiac malformations. They are at a lower risk for adverse effect of octreotide and lower threshold for commencement of octreotide may benefit them most.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16487393     DOI: 10.1111/j.1440-1754.2006.00788.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  4 in total

1.  Idiopathic congenital chylothorax treated with octreotide.

Authors:  Paulo Rego Sousa; Henrique Leitão; Maria Carmo Camacho; José Luis Nunes
Journal:  BMJ Case Rep       Date:  2010-05-19

Review 2.  Surgical chylothorax in neonates: management and outcomes.

Authors:  Karina Miura Costa; Amulya Kumar Saxena
Journal:  World J Pediatr       Date:  2018-03-05       Impact factor: 2.764

3.  Octreotide in the treatment of neonatal postoperative chylothorax: report of three cases and literature review.

Authors:  João Moreira-Pinto; Paula Rocha; Angélica Osório; Berta Bonet; Fátima Carvalho; Carlos Duarte; Luísa Oliveira
Journal:  Pediatr Surg Int       Date:  2010-09-07       Impact factor: 1.827

4.  Congenital Chylothorax of the Newborn: A Systematic Analysis of Published Cases between 1990 and 2018.

Authors:  Bernhard Resch; Gülsen Sever Yildiz; Friedrich Reiterer
Journal:  Respiration       Date:  2021-09-01       Impact factor: 3.580

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.